These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6868218)

  • 1. A comparison between the combination emepronium bromide/flavoxate and emepronium bromide in the treatment of detrusor instability.
    Aagaard J; Reuther K; Stimpel H
    Urol Int; 1983; 38(3):191-2. PubMed ID: 6868218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An objective comparison of the effects of parenterally administered drugs in patients suffering from detrusor instability.
    Cardozo LD; Stanton SL
    J Urol; 1979 Jul; 122(1):58-9. PubMed ID: 458990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence associated with detrusor instability in elderly women.
    Robinson JM; Brocklehurst JC
    Br J Urol; 1983 Aug; 55(4):371-6. PubMed ID: 6349743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavoxate hydrochloride in the treatment of detrusor instability.
    Delaere KP; Michiels HG; Debruyne FM; Moonen WA
    Urol Int; 1977; 32(5):377-81. PubMed ID: 610033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An urodynamic study of emepronium bromide in bladder dysfunction.
    Ekeland A; Sander S
    Scand J Urol Nephrol; 1976; 10(3):195-9. PubMed ID: 1006180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A second look at emepronium bromide in urinary incontinence.
    Ritch AE; George CF; Castleden CM; Hall MR
    Lancet; 1977 Mar; 1(8010):504-6. PubMed ID: 65608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of urgency by instillation of emepronium bromide in the urinary bladder.
    Obrink A; Bunne G
    Scand J Urol Nephrol; 1978; 12(3):215-8. PubMed ID: 364631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terodiline, emepronium bromide or placebo for treatment of female detrusor overactivity? A randomised, double-blind, cross-over study.
    Andersen JR; Lose G; Nørgaard M; Stimpel H; Andersen JT
    Br J Urol; 1988 Apr; 61(4):310-3. PubMed ID: 3289675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lack of effect of intramuscular emepronium bromide for urinary incontinence.
    Perera GL; Ritch AE; Hall MR
    Br J Urol; 1982 Jun; 54(3):259-60. PubMed ID: 7049303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of flavoxate hydrochloride in daily dosages of 600 versus 1200 mg for the treatment of urgency and urge incontinence.
    Milani R; Scalambrino S; Carrera S; Pezzoli P; Ruffmann R
    J Int Med Res; 1988; 16(3):244-8. PubMed ID: 3044876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oesophageal stricture associated with emepronium bromide therapy.
    Fellows IW; Ogilvie AL; Atkinson M
    Postgrad Med J; 1982 Jan; 58(675):43-4. PubMed ID: 7088761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urodynamic response of unstable bladder to flavoxate.
    Zanollo A; Catanzaro F
    Urol Int; 1980; 35(3):176-81. PubMed ID: 7385465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled, cross-over study of flavoxate in the treatment of idiopathic detrusor instability.
    Chapple CR; Parkhouse H; Gardener C; Milroy EJ
    Br J Urol; 1990 Nov; 66(5):491-4. PubMed ID: 2249117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose titration in clinical trials. An example using emepronium carrageenate in detrusor instability.
    Massey JA; Abrams P
    Br J Urol; 1986 Apr; 58(2):125-8. PubMed ID: 3516295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of detrusor hyperreflexia in multiple sclerosis: a double-blind, crossover clinical trial comparing methantheline bromide (Banthine), flavoxate chloride (Urispas) and meladrazine tartrate (Lisidonil).
    Hebjorn S
    Urol Int; 1977; 32(2-3):209-17. PubMed ID: 20683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesical instillation of emepronium bromide in defunctionalized postobstructive noncompliant bladder: an alternative to intestinal augmentation surgery?
    Aragona F; di Tonno F; Prayer-Galetti T; Maio G; Ostardo E; Passerini Glazel G
    Child Nephrol Urol; 1990; 10(1):39-43. PubMed ID: 2354466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical observations with Cetiprin (emepronium bromide).
    Hamvas A; Romics I; Balogh F
    Int Urol Nephrol; 1981; 13(2):153-5. PubMed ID: 7327890
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of emepronium bromide and flavoxate hydrochloride in the treatment of urinary incontinence.
    Stanton SL
    J Urol; 1973 Nov; 110(5):529-32. PubMed ID: 4750896
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of emepronium bromide (Cetiprin) on symptoms and urinary bladder function after transurethral resection of the prostate. A double-blind randomized trial.
    Bonnesen T; Tikjøb G; Kamper AL; Nielsen AM; Andersen JT; Jørgensen SJ
    Urol Int; 1984; 39(5):318-20. PubMed ID: 6506368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo--the drug of choice in female motor urge incontinence?
    Meyhoff HH; Gerstenberg TC; Nordling J
    Br J Urol; 1983 Feb; 55(1):34-7. PubMed ID: 6337667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.